0 CHECKOUT

PRODUCT FILTERS

REGION

CATEGORIES

  • 6
  • 3
  • 2
  • 1
  • 1
  • 1
  • 1

PRICE

6
6
7
14

PUBLISHED

0
0
7
14

PRODUCT TYPE

8
6

Search for: "Genmab A/S - Strategy and SWOT Report"

Genmab A/S - Strategy and SWOT Report

Genmab A/S - Strategy and SWOT Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and...

Published:  November 2015
Price:  From

Genmab A/S - SWOT, Strategy and Corporate Finance Report

Genmab A/S - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and...

Published:  January 2013
Price:  From

Global Chronic Lymphocytic Leukemia Therapeutics Market 2015-2019

About Chronic Lymphocytic Leukemia Chronic lymphocytic leukemia is a malignant condition characterized by increased production of lymphocytes. It has been observed that the cancer first affects B-lymphocytes...

Published:  August 2015
Price:  From

Global Rheumatoid Arthritis Drugs Market 2014-2018

About Rheumatoid Arthritis RA is a chronic disease that leads to inflammation and pain in the human body's joints such as wrists, fingers, knees, feet, and ankles. In addition, it causes inflammation...

Published:  July 2014
Price:  From

Antibody Drug Conjugates Market (2nd Edition), 2014 - 2024

Antibody drug conjugates (ADCs) are a new class of therapeutic agents, gaining increasing attention from both large and small pharmaceutical companies. Generally addressed as the marriage of an antibody...

Published:  August 2014
Price:  From

Antibody Drug Conjugates Market (3rd Edition)

The “Antibody Drug Conjugates Market (3rd edition), 2015-2025” report provides a comprehensive analysis of the current market landscape and future outlook of the growing pipeline of ADCs. The ADC market...

Published:  December 2015
Price:  From

NeuroSearch AS (NEUR) - Financial and Strategic SWOT Analysis Review

NeuroSearch AS (NEUR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by The...

Published:  May 2015
Price:  From

ALK-Abello AS (ALK B) - Financial and Strategic SWOT Analysis Review

ALK-Abello AS (ALK B) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring...

Published:  November 2015
Price:  From

Upstream Processing in Biopharmaceuticals - Increasing use of Low-Cost Disposable Bioreactors to Drive the Upstream Bioprocessing Market

Upstream Processing in Biopharmaceuticals - Increasing use of Low-Cost Disposable Bioreactors to Drive the Upstream Bioprocessing Market Summary GBI Research's report, “Upstream Processing in Biopharmaceuticals...

Published:  March 2011
Price:  From

BioInvent International AB (BINV) - Financial and Strategic SWOT Analysis Review

BioInvent International AB (BINV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled...

Published:  September 2015
Price:  From

Biopharmaceutical Contract Manufacturing Market, 2015 - 2025

Characterized by a rapidly expanding product pipeline and a capital intensive manufacturing business, the biopharmaceutical market is witnessing a growing trend towards contract manufacturing. In addition...

Published:  May 2015
Price:  From

OpportunityAnalyzer: B-Cell Non-Hodgkin's Lymphoma (NHL) - Opportunity Analysis and Forecasts to 2024

OpportunityAnalyzer: B-Cell Non-Hodgkin’s Lymphoma (NHL) - Opportunity Analysis and Forecasts to 2024 Summary Non-Hodgkin’s lymphoma (NHL) comprises a heterogeneous group of lymphoproliferative malignancies...

Published:  January 2016
Price:  From

Seattle Genetics, Inc. (SGEN) - Financial and Strategic SWOT Analysis Review

Seattle Genetics, Inc. (SGEN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled...

Published:  March 2015
Price:  From

Cancer Therapeutics 2006: Market Dynamics and R&D Trends

Together, the four major cancer markets, which include colorectal, prostate, lung and breast cancer were valued at well over $16 billion in 2005, which was an increase of 14 percent in value since 2004....

Published:  December 2005
Price:  From
Loading Indicator

Our Clients

  • Amneal Pharmaceuticals LLC.
  • Amgen Inc.
  • LEO Laboratories Ltd.
  • Pfizer Inc.
  • Roche Diagnostics Ltd.
  • Merck & Co., Inc.
  • Sanofi S.A.